27. Future perspectives for Tay-Sachs disease

Advances in Genetics

Volumn 44, Issue , 2001, Pages 349-356

  Desnick, Robert J ^a   Kaback, Michael M ^b  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ANIMAL; CHEMISTRY; GENETIC COUNSELING; GENETIC RECOMBINATION; GENETICS; HUMAN; METABOLISM; MOUSE; PSYCHOLOGICAL ASPECT; REVIEW; STEM CELL; TAY SACHS DISEASE;

ANIMALS; GENETIC COUNSELING; HUMANS; MICE; OLIGONUCLEOTIDES; RECOMBINATION, GENETIC; STEM CELLS; TAY-SACHS DISEASE;

EID: 0035232879     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2660(01)44091-0     Document Type: Review

References (36)

1. G. Bach J. Tomczak N. Risch J. Ekstein Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure Am. J. Med. Genet. 99 2001 70 75
2. C. Chavany M. Jendoubi Biology and potential strategies for the treatment of GM2 gangliosidoses Mol. Med. Today. 4 1998 158 165
3. M. Cohen-Tannoudji P. Marchand S. Akli S.A. Sheardown J.P. Puech C. Kress P. Gressens M.C. Nassogne T. Beccari A.L. Muggleton-Harris Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease Mamm. Genome. 6 1995 844 849
4. A. Cole-Strauss K. Yoon Y. Xiang B.C. Byrne M.C. Rice J. Gryn W.K. Holloman E.B. Kmiec Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide Science 273 1996 1386 1389
5. C.M. Eng C. Schechter J. Robinowitz G. Fulop T. Burgert B. Levy R. Zinberg R.J. Desnick Prenatal genetic carrier testing using triple disease screening JAMA 278 1997 1268 1272
6. J.Q. Fan S. Ishii N. Asano Y. Suzuki Accelerated transport and maturation of lysosomal-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor Nat. Med. 5 1999 112 115
7. M.J. Fernandes S. Yew D. Leclerc B. Henrissat C.E. Vorgias R.A. Gravel P. Hechtman F. Kaplan Identification of candidate active site residues in lysosomal β-hexosaminidase A. J. Biol. Chem. 272 1997 814 820
8. J.D. Flax S. Aurora C. Yang C. Simonin A.M. Wills L.L. Billinghurst M. Jendoubi R.L. Sidman J.H. Wolfe S.U. Kim E.Y. Snyder Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes Nat. Biotechnol. 16 1998 1033 1039
9. W.E. Gibbons S.A. Gitlin S.E. Lanzendorf R.A. Kaufmann R.N. Slotnick G.D. Hodgen Preimplantation genetic diagnosis for Tay-Sachs disease: Successful pregnancy after preembryo biopsy and gene amplification by polymerase chain reaction Fertil. Steril. 63 1995 723 728
10. J. Guidotti S. Akli L. Castelnau-Ptakhine A. Kahn L. Poenaru Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells Hum. Mol. Genet. 7 1998 831 838
11. J.E. Guidotti A. Mignon G. Haase C. Caillaud N. McDonell A. Kahn L. Poenaru Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice Hum. Mol. Genet. 8 1999 831 838
12. J.Q. Huang J.M. Trasler S. Igdoura J. Michaud N. Hanal R.A. Gravel Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases Hum. Mol. Genet. 6 1997 1879 1885
13. M. Jeyakumar T.D. Butters M. Cortina-Borja V. Hunnam R.L. Proia V.H. Perry R.A. Dwek F.M. Platt Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin Proc. Natl. Acad. Sci. USA 96 1999 6388 6393
14. M.M. Kaback Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model Eur. J. Pediatr. 159 2000 S192 S195
15. M. Kaback J. Lim-Steele D. Dabholkar D. Brown N. Levy K. Zeiger Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network JAMA 270 1993 2307 2315
16. G.C. Kopen D.J. Prockop D.G. Phinney Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains Proc. Natl. Acad. Sci. USA 96 1999 10711 10716
17. B.T. Kren B. Parashar P. Bandyopadhyay N.R. Chowdhury J.R. Chowdhury C.J. Steer Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type 1 with a chimeric oligonucleotide Proc. Natl. Acad. Sci. USA 96 1999 10349 10354
18. H.D. Lacorazza J.D. Flax E.Y. Snyder M. Jendoubi Expression of human β-hexosaminidase α-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells Nat. Med. 2 1996 424 429
19. Y. Liu A. Hoffmann A. Grinberg H. Westphal M.P. McDonald K.M. Miller J.N. Crawley K. Sandhoff K. Suzuki R.L. Proia Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment Proc. Natl. Acad. Sci. USA 94 1997 8138 8143
20. B.L. Mark D.J. Vocadlo S. Knapp B.L. Triggs-Raine S.G. Withers M.N. James Crystallographic evidence for substrate-assisted catalysis in a bacterial beta-hexosaminidase J. Biol. Chem. 276 2001 10330 10337
21. F. Norflus C.J. Tifft M.P. McDonald G. Goldstein J.N. Crawley A. Hoffmann K. Sandhoff K. Suzuki R.L. Proia Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations on Sandhoff disease mice J. Clin. Invest. 101 1998 1881 1888
22. V. Ourednik J. Ourednik K.I. Park E.Y. Snyder Neural stem cells — a versatile tool for cell replacement and gene therapy in the central nervous system Clin. Genet. 56 1999 267 278
23. D. Phaneuf N. Wakamatsu J.Q. Huang A. Borowski A.C. Peterson S.R. Fortunato G. Ritter S.A. Igdoura C.R. Morales G. Benoit Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases Hum. Mol. Genet. 5 1996 1 14
24. F.M. Platt T.D. Butters New therapeutic prospects for the glycosphingolipid lysosomal storage diseases Biochem. Pharmacol. 56 1998 421 430
25. F.M. Platt G.R. Neises G. Reinkensmeier M.J. Townsend V.H. Perry R.L. Proia B. Winchester R.A. Dwek T.D. Butters Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin Science 276 1997 428 431
26. K. Sango S. Yamanaka A. Hoffmann Y. Okuda A. Grinberg H. Westphal M.P. McDonald J.N. Crawley K. Sandhoff K. Suzuki Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism Nat. Genet. 11 1995 170 176
27. M.C. Snabes S.S. Chong S.B. Subramanian K. Kristjansson D. DiSepio M.R. Hughes Preimplantation single-cell analysis of multiple genetic loci by whole-genome amplification Proc. Natl. Acad. Sci. USA 91 1994 6181 6185
28. E.Y. Snyder R.M. Taylor J.H. Wolfe Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain Nature 374 1995 367 370
29. I. Tews A. Perrakis A. Oppenheim Z. Dauter K.S. Wilson C.E. Vorgias Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease Nat. Struct. Biol. 3 1996 638 648
30. C.J. Tifft R.L. Proia The-hexosaminidase deficiency disorders: Development of a clinical paradigm in the mouse Ann. Med. 29 1997 557 561
31. R. Tse G. Vavougios Y. Hou D.J. Mahuran Identification of an active acidic residue in the catalytic site of β-hexosaminidase Biochemistry 35 1996 7599 7607
32. L. Vought J. Schuette G. Bach G.A. Grabowski R.J. Desnick Tay-Sachs disease: Compatability screening in the Orthodox Jewish community Am. J. Hum. Genet. 39 1986 A183
33. C.S. Wright S.C. Li F. Rastinejad Crystal structure of human Gm2-activator protein with a novel beta-cup topology J. Mol. Biol. 304 2000 411 422
34. S. Yamanaka M.D. Johnson A. Grinberg H. Westphal J.N. Crawley M. Taniike K. Suzuki R.L. Proia Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease Proc. Natl. Acad. Sci. USA 91 1994 9975 9979
35. B.D. Yandava L.L. Billinghurst E.Y. Snyder “Global” cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain Proc. Natl. Acad. Sci. USA 96 1999 7029 7034
36. K. Yoon A. Cole-Strauss E.B. Kmiec Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA-DNA oligonucleotide Proc. Natl. Acad. Sci. USA 93 1996 2071 2076